Featured Research

from universities, journals, and other organizations

Childhood eczema and hay fever leads to adult allergic asthma, study finds

Date:
April 15, 2011
Source:
University of Melbourne
Summary:
Children who have eczema, particularly when occurring with hay fever, are nine times more likely to develop allergic asthma in their 40s, a new study reveals.

Children who have eczema, particularly when occurring with hay fever, are nine times more likely to develop allergic asthma in their 40s, a new study reveals.

The study was conducted by the University of Melbourne, the Murdoch Children's Research Institute, Menzies Research Institute and Monash University.

Published online in the Journal of Allergy and Clinical Immunology, the study reported on evidence from a clinical study of around 1400 grown up participants in the fifth decade follow-up of the Tasmanian Longitudinal Health Study (TAHS) which is the largest of its kind in the world.

In the TAHS, participants were assessed about their allergies and childhood environment in 1968, at seven years of age, and were followed up in 2004, at the age of 44.

Lead author Pamela Martin, a University of Melbourne PhD student based at the Murdoch Children Research Institute analysed the survey and skin prick testing data collected in the clinical study for the evidence of childhood eczema and hay fever leading to adult asthma. She said "In this study we see that childhood eczema, particularly when hay fever also occurs, is a very strong predictor of who will suffer from allergic asthma in adult life."

"The implications of this study are that prevention and rigorous treatment of childhood eczema and hay fever may prevent the persistence and development of asthma."

She also said this is the first study to distinguish between allergic and non-allergic asthma and their occurrence after childhood eczema and hay fever, as part of a sequence of allergic illnesses dubbed the 'atopic march'

Associate Professor Shyamali Dharmage, principal investigator of the TAHS and from the University of Melbourne's School of Population Health said currently few interventions are trialled to halt this march from childhood allergies to asthma.

"If successful strategies to stop the 'atopic march' are identified, this could ultimately save lives and health care costs related to asthma management and treatment."

The researchers estimate that up to 30 per cent of current allergic asthma within the larger population sample could be attributed to a history of childhood eczema and hay fever.


Story Source:

The above story is based on materials provided by University of Melbourne. Note: Materials may be edited for content and length.


Journal Reference:

  1. Pamela E. Martin, Melanie C. Matheson, Lyle Gurrin, John A. Burgess, Nicholas Osborne, Adrian J. Lowe, Stephen Morrison, Désirée Mészáros, Graham G. Giles, Michael J. Abramson, E. Haydn Walters, Katrina J. Allen, Shyamali C. Dharmage. Childhood eczema and rhinitis predict atopic but not nonatopic adult asthma: A prospective cohort study over 4 decades. Journal of Allergy and Clinical Immunology, 2011; DOI: 10.1016/j.jaci.2011.02.041

Cite This Page:

University of Melbourne. "Childhood eczema and hay fever leads to adult allergic asthma, study finds." ScienceDaily. ScienceDaily, 15 April 2011. <www.sciencedaily.com/releases/2011/04/110415104534.htm>.
University of Melbourne. (2011, April 15). Childhood eczema and hay fever leads to adult allergic asthma, study finds. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2011/04/110415104534.htm
University of Melbourne. "Childhood eczema and hay fever leads to adult allergic asthma, study finds." ScienceDaily. www.sciencedaily.com/releases/2011/04/110415104534.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) — The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) — Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) — America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) — China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:  

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile iPhone Android Web
          Follow Facebook Twitter Google+
          Subscribe RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins